Trade Receivables - The company has trade receivables totaling RMB 44 million from four major clients, with aging of 180 days [3]. - The audit opinion raised concerns about the recoverability of trade receivables, leading to a qualified opinion due to insufficient audit evidence [5]. - Management believes that the audit qualification will not adversely affect the company's financial position or operations [6]. - The company plans to establish repayment agreements with clients by June 2022, outlining payment timelines and amounts [9]. - If receivables are not collected by October 2022, the company reserves the right to take legal action for collection [9]. - Management has communicated with clients to negotiate repayment plans and has already recovered some receivables [6]. - The company emphasizes the importance of maintaining close communication with clients regarding their operational status and willingness to repay [9]. Audit Opinion - The audit committee reviewed the qualified opinion and agreed with management's assessment regarding the risks of uncollectible receivables [8]. - The audit committee believes that the qualified opinion will not negatively impact the company's normal operations [8]. - The company expects to remove the audit qualification from its financial statements by the end of 2022 [9].
中国医疗集团(08225) - 2021 Q4 - 年度财报